Breadcrumb
- Home
- Policy & Compliance
- Policy Topics
- Early Stage Investigator (ESI) Policies
- History of NIH Support for Early Career Investigators
Main navigation (Sidebar Template)
-
Policy & Compliance
-
Implementation of New Initiatives and Policies
-
NIH Grants and Funding Information Status
-
Common Forms for Biographical Sketch and Current and Pending (Other) Support
-
Simplified Review Framework for Most Research Project Grants (RPGs)
-
Revisions to the NIH Fellowship Application and Review Process
-
Updates to NIH Institutional Training Grant Applications
-
Reference Letters
-
Updated Application Forms and Instructions (FORMS-I)
-
NIH Grants and Funding Information Status
-
Grants Policy Statement
-
Notices of Policy Changes
-
Compliance & Oversight
-
Policy Topics
-
Animal Welfare
-
Animals in NIH Research
-
Why Animals are Used in Research
-
How Animals Have Helped Improve Public Health
-
Adoption of Laboratory Animals after Research
-
Why Properly Designed Experiments are Critical to Animal Research and Advancing Public Health
-
Ensuring the Care of Research Animals
-
When Are Alternatives to Animals Used in Research
-
Why Animals are Used in Research
-
Clinical Trial Requirements for Grants and Contracts
-
NIH's Definition of a Clinical Trial
-
Decision Tool: Does Your Human Subjects Study Meet the NIH Definition of a Clinical Trial?
-
Basic Experimental Studies Involving Humans (BESH)
-
Clinical Trial-Specific Funding Opportunities
-
Clinical Trial-Specific Review Criteria
-
Good Clinical Practice Training
-
Human Subjects System
-
Human Subjects and Clinical Trials Information Form
-
Posting Clinical Trial Informed Consent Forms
-
Protocol Templates for Clinical Trials
- Requirements for Registering & Reporting NIH-Funded Clinical Trials
-
Information about NIH Clinical Trial Stewardship
-
Training & Resources for NIH Clinical Trial Policies
-
NIH's Definition of a Clinical Trial
-
Communicating, and Acknowledging Federal Funding
-
Early Stage Investigator Policies
-
NIH Early Stage Investigators Policy
-
Determining Early Stage Investigator (ESI) Status
-
Early Stage Investigator Extensions
-
Early Stage Investigator Related Data
-
History of NIH Support for Early Career Investigators
-
Related Notices, Laws, Statements and Reports
-
List of smaller grants & awards that maintain ESI status
-
NIH Early Stage Investigators Policy
-
Family-Friendly Initiatives
- Financial Conflict of Interest
- Foreign Interference
-
Human Subjects Research
- Definition of Human Subjects Research
- Pre-Award and Post-Award Processes for Projects Involving Human Subjects Research
- Certificates of Confidentiality
-
Clinical Trial Requirements for Grants and Contracts
-
Inclusion Policies for Human Subjects Research
- Single IRB for Multi-Site or Cooperative Research
- Policies & Regulations for Human Subjects
-
Training & Resources for Human Subjects
-
Inclusion Policies for Human Subjects Research
- Intellectual Property Policy
-
Lobbying Guidance for Recipient Activities
-
Natural Disasters
-
Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding
-
Applicant/Recipient COVID-19 Update History
-
Funding Opportunities Specific to COVID-19
-
NIH Implementation of OMB Memorandum M-20-26 “Extension of Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations” dated June 18, 2020
-
Review Process during COVID-19 Pandemic
-
The Impact of COVID-19 on the Research Community
-
Applicant/Recipient COVID-19 Update History
-
Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding
- Next Generation Researchers Initiative
- NIH Fiscal Policies
-
Peer Review Policies and Practices
- Public Access
- Research Integrity
- Research Misconduct
-
Rigor and Reproducibility
-
Principles and Guidelines for Publishing Preclinical Research
-
Guidance: Rigor and Reproducibility in Grant Applications
-
Resources for Preparing Your Application
-
Training and Other Resources for Rigor and Reproducibility
-
Meetings and Workshops for Rigor and Reproducibility
-
Notices, Blog Posts, and References for Rigor and Reproducibility
-
Principles and Guidelines for Publishing Preclinical Research
-
Select Agent Information
-
Subawards
-
Submission Policies
-
Supporting a Safe and Respectful Workplace
-
Scientific Data Sharing: Policies and Access to Data
-
Data Management and Sharing Policy
-
Genomic Data Sharing Policy
-
Genomic Data Sharing Policy Overview
-
Developing Genomic Data Sharing Plans
-
About Institutional Certifications
-
Completing an Institutional Certification Form
-
Genomic Data Sharing Expectations by NIH Institute & Center
-
Data Submission and Release Expectations
-
Where to Submit Genomic Data
-
How to Register and Submit a Study in dbGaP
-
GDS IC Contacts​
-
Genomic Data Sharing Policy Overview
- Other Sharing Policies​
-
Accessing Data & Publications
-
NIH Security Best Practices for Controlled-Access Data and Repositories
-
Accessing Scientific Data
-
Accessing Genomic Data from NIH Repositories
-
How to Request and Access Datasets from dbGaP
-
Using Genomic Data Responsibly Under the NIH Genomic Data Sharing Policy
-
Genomic Data User Code of Conduct
-
NIH Data Use Certification Agreement
-
NIH Security Best Practices for Controlled-Access Data and Repositories
-
Which Policies Apply to My Research?
-
Data Management and Sharing Policy
-
Animal Welfare
-
Implementation of New Initiatives and Policies
History of NIH Support for Early Career Investigators
August, 2017
NIH published the Policy Supporting the Next Generation Researchers Initiative.
October 2011
NIH announced an update of receipt dates for New Investigator resubmissions.
October 2010
NIH announced the NIH Director’s Early Independence Award (DP5) that allows highly promising candidates to launch an independent research career without a period of postdoctoral training.
August 2009
NIH encouraged New and Early Stage Investigators to keep their Commons Profiles up to date.
December 2008
NIH established a way to extend the Early Stage Investigator period to accommodate illness, parental responsibilities, military service and other factors that might result in time away from research.
November 2008
NIH fully implemented the Early Stage Investigator (ESI) Policy and created the ability to identify New Investigator and ESI using data in eRA Commons Profiles.
October 2008
NIH clarified New and Early Stage Investigator policies and established comparable success rates for New and Established investigators on Type 1 (new) R01 Equivalent applications. It also indicated that half of the New Investigator pool each year should be Early Stage Investigators. Compliance was encouraged by developing and sending frequent status reports to the funding NIH institutes and centers during the course of each fiscal year. This also ended the period of using a five-year rolling average of New Investigators as the New Investigator target for future years.
September 2008
NIH modified the New Investigator Policy to identify Early Stage Investigators (ESI) based on the eligibility criteria associated with the Director’s New Innovator Awards.
February 2007
NIH announced a Request for Applications for the NIH Director’s New Innovator Awards (DP2) and a follow-on funding opportunity announcement was released in March, 2007. Awards were restricted to New Investigators who are within 10 years of completing their terminal research degree or their medical residency. Awards were for 5 years and up to $300,000 direct costs per year.
December 2006
NIH articulated a policy that had been in place for several years that created a numerical target for the number of New Investigators based on the average number of New Investigators with awards over the last five years.
November 2006
NIH established the Multiple Principal Investigator policy to support team science projects. An application in which all Multiple Principal Investigators are identified as New Investigator is treated as a New Investigator application.
January 2006
NIH launched the Pathway to Independence Award program (K99/R00) that includes a period of postdoctoral research support followed by up to three years of independent research support upon finding a suitable position.
November 2005
Launched a pilot study to shorten review cycle for New Investigator R01 applications to permit submission of an amended application by the next submission date. The policy was fully implemented by August, 2007.
December 2004
The definition of New Investigator was modified to include anyone who has not previously competed successfully for an NIH grant similar to an R01. Previously, it had been restricted to those who had not previously served as a principal investigator on an R01. NIH establishes a website for New Investigators.
November 1998
The NIH created a check box on the face page of the NIH grant application to identify R01 applications submitted by New Investigators.
December 1997
Transition to a New NIH Policy on New Investigators – A transition period was described during which R29 applications were phased out and New Investigators were advised to submit R01 applications that were marked to indicate that the PD/PI was a New Investigator.
November 1997
Elimination of NIH FIRST (R29) Award – Based on a report the NIH Advisory Committee to the Director eliminated the FIRST award and New Investigators were encouraged to apply for R01s asking for a level and period of support necessary for their project.
August 1986
First Independent Research Support and Transition (FIRST) Award (PDF, 792 KB) - FIRST Awards (R29) had a direct cost limit of $100,000 in any year and were limited to $350,000 direct costs over the five year award period. FIRST awards were used between 1986 and 1997.
June 1977
New Investigator Research Awards (NIRA) (PDF, 396 KB) - NIRA awards (R23) had direct cost amounts up to $35,000 for up to three years. These awards were used between 1977 and 1986.
This page last updated on: February 10, 2023
For technical issues E-mail OER Webmaster